Eva Medtec, Inc.

Eva Medtec is pioneering the future of pain relief and recovery through Neural-Fascia-Lymphatic Activation™. Our flagship product, the Neuroglide® Pain Relief & Recovery System, is an FDA-cleared, non-invasive medical device that automates the benefits of manual therapy by rhythmically stimulating the back and neck with patented air-bladder technology. Clinically validated using Near-Infrared Fluorescence Lymphatic Imaging (NIRFLI), Neuroglide has been shown to accelerate lymphatic flow up to 3x baseline and support relief from pain, post-op Eva Medtec’s innovation is a new patented, FDA-cleared, over the counter (OTC) medical device that simulates and automates Manual Lymphatic Drainage (MLD) therapy and Myofascial Manipulation (MM) to bring about pain relief and reduce inflammation. The basic principle is that the Neuroglide enables your body to naturally heal itself. The device consists of 16 inflation chambers incorporated into a back pad that sequentially inflate against the body’s soft tissues to bring about pain relief. This action, when combined, increases lymphatic circulation, removes toxins, calms the nervous system, and quiets the nerve receptors. Additionally, it is portable and can be used in clinics, hospitals or at home. Eva Medtec’s mission is to pioneer advanced medical devices that relieve pain, without the use of opioids, utilizing lymphatic circulation and nervous system manipulation to address a $38 Billion dollar market. Eva Medtec is led by serial entrepreneur and inventor, Irene Waldridge, who has now set her sights on the pain management market using natural pain. Prior to Eva Medtec, she founded Tactile Medical, where she pioneered a new care market for Lymphedema with her Flexitouch device, which is still the gold standard in care. Eva Medtec devices are made in the USA, in a FDA-registered facility located in Shakopee, MN, where devices are assembled and tested in-house. See www.neuroglide.com website for more information.